Triple-Negative Breast Cancer | P Kelly Marcom, MD

Beyond the Guidelines: Clinical Investigator Perspectives on the Management of Triple-Negative Breast Cancer — Faculty Presentation 4: Current and Future Role of PARP Inhibitors for Patients with TNBC and a BRCA Mutation — Dr Marcom. CME information and select publications